ZB
BLFS icon

Zions Bancorporation’s BioLife Solutions BLFS Stock Holding History

Zions Bancorporation’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-394
Closed -$7.17K – 929
2022
Q4 		$7.17K Buy
+394
New +$8.13K ﹤0.01% 782

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Zions Bancorporation's BLFS Position: Q1 2023 in Review

Zions Bancorporation sold out of BioLife Solutions (BLFS) in Q1 2023, closing a stake of 394 shares — an estimated $7.17K sold.

Zions Bancorporation first reported a position in BLFS in Q4 2022 and held it in 1 quarter. The position peaked at $7.17K in Q4 2022. 169 funds tracked by Wall St. Rank hold BLFS as of Q1 2023.

  • Zions Bancorporation reported no remaining BioLife Solutions position as of Q1 2023 after selling out during the quarter.
  • Zions Bancorporation sold 394 BioLife Solutions shares in Q1 2023, an estimated $7.17K.
  • Zions Bancorporation first reported a position in BioLife Solutions in Q4 2022 and held it in 1 quarter.
  • Zions Bancorporation's BioLife Solutions position peaked at $7.17K in Q4 2022.
  • 169 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2023.

Based on Zions Bancorporation's 13F filing for Q1 2023, filed 10 May 2023.